HEADER IMMUNE SYSTEM 13-DEC-21 7QHP TITLE STRUCTURE OF I-AG7 WITH A BOUND HYBRID INSULIN PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-D ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 OTHER_DETAILS: THIS POLYPEPTIDE CORRESPONDS TO THE ALPHA CHAIN OF A COMPND 7 MURINE MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS II MOLECULE.; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: MURINE MHC CLASS II I-A BETA G7; COMPND 10 CHAIN: B; COMPND 11 ENGINEERED: YES; COMPND 12 OTHER_DETAILS: HYBRID INSULIN PEPTIDE COVALENTLY BOUND THROUGH COMPND 13 GLYCINE-SERINE LINKER TO N-TERMINAL OF POLYPEPTIDE; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: INSULIN-1; COMPND 16 CHAIN: T; COMPND 17 ENGINEERED: YES; COMPND 18 OTHER_DETAILS: THIS PEPTIDE REPRESENTS THE RESULT OF A FUSION OF COMPND 19 FRAGMENTS DERIVED FROM CHROMOGRANIN A AND INSULIN C. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: H2-AA; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: CHO-S; SOURCE 9 EXPRESSION_SYSTEM_ORGAN: OVARY; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 12 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 13 ORGANISM_TAXID: 10090; SOURCE 14 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 16 EXPRESSION_SYSTEM_CELL_LINE: CHO-S; SOURCE 17 EXPRESSION_SYSTEM_ORGAN: OVARY; SOURCE 18 MOL_ID: 3; SOURCE 19 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 20 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 21 ORGANISM_TAXID: 10090; SOURCE 22 GENE: INS1, INS-1; SOURCE 23 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 10029 KEYWDS DIABETES, MHC CLASS II, HYBRID INSULIN PEPTIDE, AUTOIMMUNE DISEASE, KEYWDS 2 IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.LOPEZ-SAGASETA,E.ERAUSQUIN REVDAT 6 23-OCT-24 7QHP 1 REMARK REVDAT 5 31-JAN-24 7QHP 1 REMARK REVDAT 4 24-AUG-22 7QHP 1 JRNL REVDAT 3 17-AUG-22 7QHP 1 JRNL REVDAT 2 10-AUG-22 7QHP 1 JRNL REVDAT 1 20-JUL-22 7QHP 0 JRNL AUTH E.ERAUSQUIN,P.SERRA,D.PARRAS,P.SANTAMARIA,J.LOPEZ-SAGASETA JRNL TITL STRUCTURAL PLASTICITY IN I-A G7 LINKS AUTOREACTIVITY TO JRNL TITL 2 HYBRID INSULIN PEPTIDES IN TYPE I DIABETES. JRNL REF FRONT IMMUNOL V. 13 24311 2022 JRNL REFN ESSN 1664-3224 JRNL PMID 35967292 JRNL DOI 10.3389/FIMMU.2022.924311 REMARK 2 REMARK 2 RESOLUTION. 1.82 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.41 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 44352 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2217 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 54.4100 - 4.5900 0.99 2770 160 0.1899 0.2195 REMARK 3 2 4.5800 - 3.6400 0.99 2669 144 0.1577 0.1867 REMARK 3 3 3.6400 - 3.1800 1.00 2649 141 0.1628 0.1812 REMARK 3 4 3.1800 - 2.8900 1.00 2635 153 0.1817 0.2213 REMARK 3 5 2.8900 - 2.6800 1.00 2652 133 0.1890 0.2256 REMARK 3 6 2.6800 - 2.5200 1.00 2619 132 0.1911 0.2312 REMARK 3 7 2.5200 - 2.4000 1.00 2609 146 0.1888 0.2203 REMARK 3 8 2.4000 - 2.2900 1.00 2633 125 0.1775 0.2381 REMARK 3 9 2.2900 - 2.2000 1.00 2609 159 0.1811 0.2325 REMARK 3 10 2.2000 - 2.1300 1.00 2631 118 0.1874 0.2660 REMARK 3 11 2.1300 - 2.0600 1.00 2613 130 0.1974 0.2827 REMARK 3 12 2.0600 - 2.0000 1.00 2592 153 0.2089 0.2589 REMARK 3 13 2.0000 - 1.9500 1.00 2624 122 0.2085 0.2532 REMARK 3 14 1.9500 - 1.9000 1.00 2631 124 0.2184 0.2553 REMARK 3 15 1.9000 - 1.8600 1.00 2607 143 0.2410 0.2955 REMARK 3 16 1.8600 - 1.8200 1.00 2592 134 0.2774 0.3161 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.207 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.164 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.68 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 3034 REMARK 3 ANGLE : 0.943 4149 REMARK 3 CHIRALITY : 0.066 466 REMARK 3 PLANARITY : 0.008 534 REMARK 3 DIHEDRAL : 6.695 411 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7QHP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-DEC-21. REMARK 100 THE DEPOSITION ID IS D_1292119506. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAR-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALBA REMARK 200 BEAMLINE : XALOC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979185 REMARK 200 MONOCHROMATOR : SI(111) CHANNEL-CUT REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC 1.0.5 REMARK 200 DATA SCALING SOFTWARE : AUTOPROC 1.0.5 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44356 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.820 REMARK 200 RESOLUTION RANGE LOW (A) : 70.254 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 4.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 70.25 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.03700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 30.40 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC 5.8.0267 REMARK 200 STARTING MODEL: 1MUJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.17 M AMMONIUM SULFATE, 25% W/V PEG REMARK 280 4000, 15% GLYCEROL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.02750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 49.02750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 45.99800 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 54.40950 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 45.99800 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 54.40950 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 49.02750 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 45.99800 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 54.40950 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 49.02750 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 45.99800 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 54.40950 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -69.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, T REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A -1 REMARK 465 ASP A 0 REMARK 465 ASP A 1 REMARK 465 GLU A 183 REMARK 465 ILE A 184 REMARK 465 PRO A 185 REMARK 465 ALA A 186 REMARK 465 PRO A 187 REMARK 465 MET A 188 REMARK 465 SER A 189 REMARK 465 GLU A 190 REMARK 465 LEU A 191 REMARK 465 THR A 192 REMARK 465 GLU A 193 REMARK 465 SER A 194 REMARK 465 LEU A 195 REMARK 465 GLU A 196 REMARK 465 VAL A 197 REMARK 465 LEU A 198 REMARK 465 PHE A 199 REMARK 465 GLN A 200 REMARK 465 LEU B -25 REMARK 465 GLN B -24 REMARK 465 THR B -23 REMARK 465 LEU B -22 REMARK 465 ALA B -21 REMARK 465 LEU B -20 REMARK 465 GLU B -19 REMARK 465 VAL B -18 REMARK 465 GLU B -17 REMARK 465 ASP B -16 REMARK 465 ASP B -15 REMARK 465 PRO B -14 REMARK 465 CYS B -13 REMARK 465 GLY B -12 REMARK 465 GLY B -11 REMARK 465 GLY B -10 REMARK 465 GLY B -9 REMARK 465 GLY B -8 REMARK 465 SER B -7 REMARK 465 GLY B -6 REMARK 465 GLY B -5 REMARK 465 GLY B -4 REMARK 465 SER B -3 REMARK 465 GLY B -2 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 GLY B 1 REMARK 465 ASP B 2 REMARK 465 SER B 3 REMARK 465 GLY B 167 REMARK 465 GLN B 190 REMARK 465 SER B 191 REMARK 465 GLU B 192 REMARK 465 SER B 193 REMARK 465 ALA B 194 REMARK 465 ARG B 195 REMARK 465 SER B 196 REMARK 465 LYS B 197 REMARK 465 SER B 198 REMARK 465 LEU B 199 REMARK 465 GLU B 200 REMARK 465 VAL B 201 REMARK 465 LEU B 202 REMARK 465 PHE B 203 REMARK 465 GLN B 204 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 3 CG CD OE1 OE2 REMARK 470 GLY A 11 O REMARK 470 SER A 17 OG REMARK 470 ASP A 39 CG OD1 OD2 REMARK 470 LYS A 40 CG CD CE NZ REMARK 470 LYS A 41 CG CD CE NZ REMARK 470 LYS A 42 CG CD CE NZ REMARK 470 LYS A 69 CE NZ REMARK 470 LYS A 77 CG CD CE NZ REMARK 470 GLU A 87 OE2 REMARK 470 GLN A 90 CG CD OE1 NE2 REMARK 470 LEU A 101 CG CD1 CD2 REMARK 470 GLN A 103 CD OE1 NE2 REMARK 470 ASN A 120 OD1 REMARK 470 ARG A 125 NH1 NH2 REMARK 470 LYS A 128 CG CD CE NZ REMARK 470 VAL A 130 CG1 CG2 REMARK 470 ARG A 143 CG CD NE CZ NH1 NH2 REMARK 470 SER A 158 OG REMARK 470 ASP A 159 CG OD1 OD2 REMARK 470 ASP A 160 CG OD1 OD2 REMARK 470 ILE A 162 CD1 REMARK 470 GLU A 173 CG CD OE1 OE2 REMARK 470 GLU A 174 CG CD OE1 OE2 REMARK 470 PRO A 175 CG CD REMARK 470 GLU B 4 N CA CB CG CD OE1 OE2 REMARK 470 ARG B 5 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 22 CG CD OE1 NE2 REMARK 470 ARG B 23 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 48 NE CZ NH1 NH2 REMARK 470 GLU B 52 CG CD OE1 OE2 REMARK 470 ARG B 55 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 59 CD OE1 OE2 REMARK 470 LYS B 63 CG CD CE NZ REMARK 470 ARG B 104 CG CD NE CZ NH1 NH2 REMARK 470 THR B 105 OG1 CG2 REMARK 470 HIS B 111 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 125 CG CD CE NZ REMARK 470 LYS B 127 CD CE NZ REMARK 470 ARG B 129 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 132 NH2 REMARK 470 GLN B 135 CG CD OE1 NE2 REMARK 470 THR B 138 OG1 CG2 REMARK 470 VAL B 139 CG1 CG2 REMARK 470 GLN B 145 CG CD OE1 NE2 REMARK 470 THR B 163 O REMARK 470 GLN B 166 CG CD OE1 NE2 REMARK 470 GLU B 168 CG CD OE1 OE2 REMARK 470 LYS B 180 CG CD CE NZ REMARK 470 SER B 181 OG REMARK 470 GLU B 186 CG CD OE1 OE2 REMARK 470 ARG B 188 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 505 O HOH B 514 2.16 REMARK 500 OH TYR A 15 OD1 ASP A 20 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 550 O HOH A 550 4555 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 33 -106.79 50.97 REMARK 500 THR B 88 -73.91 -120.17 REMARK 500 THR B 88 -74.45 -120.17 REMARK 500 THR B 138 -60.95 -100.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B 304 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 LYS B 127 O REMARK 620 2 HIS B 173 O 69.8 REMARK 620 N 1 DBREF 7QHP A -1 193 UNP P04228 HA2D_MOUSE 24 218 DBREF 7QHP B -25 204 PDB 7QHP 7QHP -25 204 DBREF 7QHP T -1 11 UNP P01325 INS1_MOUSE 75 87 SEQADV 7QHP CYS A 74 UNP P04228 ILE 99 ENGINEERED MUTATION SEQADV 7QHP SER A 194 UNP P04228 EXPRESSION TAG SEQADV 7QHP LEU A 195 UNP P04228 EXPRESSION TAG SEQADV 7QHP GLU A 196 UNP P04228 EXPRESSION TAG SEQADV 7QHP VAL A 197 UNP P04228 EXPRESSION TAG SEQADV 7QHP LEU A 198 UNP P04228 EXPRESSION TAG SEQADV 7QHP PHE A 199 UNP P04228 EXPRESSION TAG SEQADV 7QHP GLN A 200 UNP P04228 EXPRESSION TAG SEQADV 7QHP GLU T 7 UNP P01325 ALA 83 CONFLICT SEQADV 7QHP ASP T 8 UNP P01325 ARG 84 CONFLICT SEQADV 7QHP ASP T 9 UNP P01325 GLN 85 CONFLICT SEQADV 7QHP PRO T 10 UNP P01325 LYS 86 CONFLICT SEQADV 7QHP CYS T 11 UNP P01325 ARG 87 CONFLICT SEQRES 1 A 202 GLU ASP ASP ILE GLU ALA ASP HIS VAL GLY PHE TYR GLY SEQRES 2 A 202 THR THR VAL TYR GLN SER PRO GLY ASP ILE GLY GLN TYR SEQRES 3 A 202 THR HIS GLU PHE ASP GLY ASP GLU LEU PHE TYR VAL ASP SEQRES 4 A 202 LEU ASP LYS LYS LYS THR VAL TRP ARG LEU PRO GLU PHE SEQRES 5 A 202 GLY GLN LEU ILE LEU PHE GLU PRO GLN GLY GLY LEU GLN SEQRES 6 A 202 ASN ILE ALA ALA GLU LYS HIS ASN LEU GLY CYS LEU THR SEQRES 7 A 202 LYS ARG SER ASN PHE THR PRO ALA THR ASN GLU ALA PRO SEQRES 8 A 202 GLN ALA THR VAL PHE PRO LYS SER PRO VAL LEU LEU GLY SEQRES 9 A 202 GLN PRO ASN THR LEU ILE CYS PHE VAL ASP ASN ILE PHE SEQRES 10 A 202 PRO PRO VAL ILE ASN ILE THR TRP LEU ARG ASN SER LYS SEQRES 11 A 202 SER VAL THR ASP GLY VAL TYR GLU THR SER PHE LEU VAL SEQRES 12 A 202 ASN ARG ASP HIS SER PHE HIS LYS LEU SER TYR LEU THR SEQRES 13 A 202 PHE ILE PRO SER ASP ASP ASP ILE TYR ASP CYS LYS VAL SEQRES 14 A 202 GLU HIS TRP GLY LEU GLU GLU PRO VAL LEU LYS HIS TRP SEQRES 15 A 202 GLU PRO GLU ILE PRO ALA PRO MET SER GLU LEU THR GLU SEQRES 16 A 202 SER LEU GLU VAL LEU PHE GLN SEQRES 1 B 230 LEU GLN THR LEU ALA LEU GLU VAL GLU ASP ASP PRO CYS SEQRES 2 B 230 GLY GLY GLY GLY GLY SER GLY GLY GLY SER GLY GLY SER SEQRES 3 B 230 GLY ASP SER GLU ARG HIS PHE VAL HIS GLN PHE LYS GLY SEQRES 4 B 230 GLU CYS TYR PHE THR ASN GLY THR GLN ARG ILE ARG LEU SEQRES 5 B 230 VAL THR ARG TYR ILE TYR ASN ARG GLU GLU TYR LEU ARG SEQRES 6 B 230 PHE ASP SER ASP VAL GLY GLU TYR ARG ALA VAL THR GLU SEQRES 7 B 230 LEU GLY ARG HIS SER ALA GLU TYR TYR ASN LYS GLN TYR SEQRES 8 B 230 LEU GLU ARG THR ARG ALA GLU LEU ASP THR ALA CYS ARG SEQRES 9 B 230 HIS ASN TYR GLU GLU THR GLU VAL PRO THR SER LEU ARG SEQRES 10 B 230 ARG LEU GLU GLN PRO ASN VAL ALA ILE SER LEU SER ARG SEQRES 11 B 230 THR GLU ALA LEU ASN HIS HIS ASN THR LEU VAL CYS SER SEQRES 12 B 230 VAL THR ASP PHE TYR PRO ALA LYS ILE LYS VAL ARG TRP SEQRES 13 B 230 PHE ARG ASN GLY GLN GLU GLU THR VAL GLY VAL SER SER SEQRES 14 B 230 THR GLN LEU ILE ARG ASN GLY ASP TRP THR PHE GLN VAL SEQRES 15 B 230 LEU VAL MET LEU GLU MET THR PRO HIS GLN GLY GLU VAL SEQRES 16 B 230 TYR THR CYS HIS VAL GLU HIS PRO SER LEU LYS SER PRO SEQRES 17 B 230 ILE THR VAL GLU TRP ARG ALA GLN SER GLU SER ALA ARG SEQRES 18 B 230 SER LYS SER LEU GLU VAL LEU PHE GLN SEQRES 1 T 13 LEU GLN THR LEU ALA LEU GLU VAL GLU ASP ASP PRO CYS HET GOL A 301 6 HET SO4 B 301 5 HET GOL B 302 6 HET NA B 303 1 HET NA B 304 1 HETNAM GOL GLYCEROL HETNAM SO4 SULFATE ION HETNAM NA SODIUM ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 GOL 2(C3 H8 O3) FORMUL 5 SO4 O4 S 2- FORMUL 7 NA 2(NA 1+) FORMUL 9 HOH *295(H2 O) HELIX 1 AA1 LEU A 47 ILE A 54 1 8 HELIX 2 AA2 GLU A 57 SER A 79 1 23 HELIX 3 AA3 THR B 51 LEU B 53 5 3 HELIX 4 AA4 GLY B 54 ALA B 76 1 23 HELIX 5 AA5 ALA B 76 THR B 84 1 9 SHEET 1 AA1 8 LYS A 42 TRP A 45 0 SHEET 2 AA1 8 ASP A 31 ASP A 37 -1 N TYR A 35 O VAL A 44 SHEET 3 AA1 8 ILE A 21 PHE A 28 -1 N HIS A 26 O LEU A 33 SHEET 4 AA1 8 HIS A 6 PHE A 9 -1 N PHE A 9 O GLU A 27 SHEET 5 AA1 8 PHE B 7 THR B 18 -1 O CYS B 15 N GLY A 8 SHEET 6 AA1 8 ARG B 23 TYR B 32 -1 O ARG B 25 N TYR B 16 SHEET 7 AA1 8 GLU B 35 ASP B 41 -1 O GLU B 35 N TYR B 32 SHEET 8 AA1 8 TYR B 47 ALA B 49 -1 O ARG B 48 N ARG B 39 SHEET 1 AA2 8 LYS A 42 TRP A 45 0 SHEET 2 AA2 8 ASP A 31 ASP A 37 -1 N TYR A 35 O VAL A 44 SHEET 3 AA2 8 ILE A 21 PHE A 28 -1 N HIS A 26 O LEU A 33 SHEET 4 AA2 8 THR A 13 SER A 17 -1 N GLN A 16 O ILE A 21 SHEET 5 AA2 8 PHE B 7 THR B 18 -1 O PHE B 7 N SER A 17 SHEET 6 AA2 8 ARG B 23 TYR B 32 -1 O ARG B 25 N TYR B 16 SHEET 7 AA2 8 GLU B 35 ASP B 41 -1 O GLU B 35 N TYR B 32 SHEET 8 AA2 8 TYR B 47 ALA B 49 -1 O ARG B 48 N ARG B 39 SHEET 1 AA3 4 GLN A 90 PRO A 95 0 SHEET 2 AA3 4 ASN A 105 ILE A 114 -1 O ASP A 112 N GLN A 90 SHEET 3 AA3 4 PHE A 147 PHE A 155 -1 O LEU A 153 N LEU A 107 SHEET 4 AA3 4 TYR A 135 GLU A 136 -1 N TYR A 135 O TYR A 152 SHEET 1 AA4 4 GLN A 90 PRO A 95 0 SHEET 2 AA4 4 ASN A 105 ILE A 114 -1 O ASP A 112 N GLN A 90 SHEET 3 AA4 4 PHE A 147 PHE A 155 -1 O LEU A 153 N LEU A 107 SHEET 4 AA4 4 LEU A 140 VAL A 141 -1 N LEU A 140 O HIS A 148 SHEET 1 AA5 4 LYS A 128 VAL A 130 0 SHEET 2 AA5 4 ASN A 120 ARG A 125 -1 N ARG A 125 O LYS A 128 SHEET 3 AA5 4 TYR A 163 GLU A 168 -1 O LYS A 166 N THR A 122 SHEET 4 AA5 4 VAL A 176 TRP A 180 -1 O VAL A 176 N VAL A 167 SHEET 1 AA6 4 ASN B 97 LEU B 102 0 SHEET 2 AA6 4 ASN B 112 PHE B 121 -1 O VAL B 115 N SER B 101 SHEET 3 AA6 4 PHE B 154 MET B 162 -1 O MET B 162 N ASN B 112 SHEET 4 AA6 4 VAL B 141 SER B 143 -1 N SER B 142 O MET B 159 SHEET 1 AA7 4 ASN B 97 LEU B 102 0 SHEET 2 AA7 4 ASN B 112 PHE B 121 -1 O VAL B 115 N SER B 101 SHEET 3 AA7 4 PHE B 154 MET B 162 -1 O MET B 162 N ASN B 112 SHEET 4 AA7 4 ILE B 147 ARG B 148 -1 N ILE B 147 O GLN B 155 SHEET 1 AA8 4 GLN B 135 GLU B 136 0 SHEET 2 AA8 4 LYS B 127 ARG B 132 -1 N ARG B 132 O GLN B 135 SHEET 3 AA8 4 VAL B 169 GLU B 175 -1 O HIS B 173 N ARG B 129 SHEET 4 AA8 4 ILE B 183 ARG B 188 -1 O TRP B 187 N TYR B 170 SSBOND 1 CYS A 74 CYS T 11 1555 1555 2.99 SSBOND 2 CYS A 109 CYS A 165 1555 1555 2.01 SSBOND 3 CYS B 15 CYS B 77 1555 1555 2.08 SSBOND 4 CYS B 116 CYS B 172 1555 1555 2.02 LINK O LYS B 127 NA NA B 304 1555 1555 3.11 LINK O HIS B 173 NA NA B 304 1555 1555 3.12 CISPEP 1 SER A 17 PRO A 18 0 -0.49 CISPEP 2 PHE A 115 PRO A 116 0 -4.21 CISPEP 3 TYR B 122 PRO B 123 0 0.38 CRYST1 91.996 108.819 98.055 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010870 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009190 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010198 0.00000